|
(2) The power to modify the scope of practice |
restrictions under any licensing act administered by the |
Department for any person working under the direction of |
the Illinois Emergency Management Agency and the Illinois |
Department of Public Health pursuant to the declared |
disaster. |
(3) The power to expand the exemption in Section 4(a) |
of the Pharmacy Practice Act to those licensed |
professionals whose scope of practice has been modified, |
under paragraph (2) of subsection (a) of this Section, to |
include any element of the practice of pharmacy as defined |
in the Pharmacy Practice Act for any person working under |
the direction of the Illinois Emergency Management Agency |
and the Illinois Department of Public Health pursuant to |
the declared disaster. |
(b) Persons exempt from licensure under paragraph (1) of |
subsection (a) of this Section and persons operating under |
modified scope of practice provisions under paragraph (2) of |
subsection (a) of this Section shall be exempt from licensure |
or be subject to modified scope of practice only until the |
declared disaster has ended as provided by law. For purposes |
of this Section, persons working under the direction of an |
emergency services and disaster agency accredited by the |
Illinois Emergency Management Agency and a local public health |
department, pursuant to a declared disaster, shall be deemed |
to be working under the direction of the Illinois Emergency |
|
Management Agency and the Department of Public Health.
|
(c) The Secretary or the Director, as his or her designee, |
shall exercise these powers by way of proclamation.
|
(d) Any person who was issued a temporary out-of-state |
permit by the Department pursuant to a proclamation issued by |
the Secretary or related action by the Director in response to |
the COVID-19 pandemic may continue to practice under his or |
her temporary out-of-state permit if he or she submits an |
application for licensure by endorsement to the Department on |
or before May 11, 2023. Any such person may continue to |
practice under his or her temporary out-of-state permit until |
the Department issues the license or denies the application, |
at which time the temporary out-of-state permit shall expire. |
If the Department does not issue the license or does
not deny |
the application by May 11, 2024, the temporary out-of-state |
permit shall expire. If the person holding a temporary |
out-of-state permit does not submit an application for |
licensure by endorsement to the Department on or before May |
11, 2023, the temporary out-of-state COVID permit shall expire |
on that date. The Secretary may extend the May 11, 2023 |
deadline under this subsection for an additional 60 days. This |
subsection applies to the following licensed professions: |
physician; registered nurse; practical nurse; advanced |
practice registered nurse; full practice advanced practice |
registered nurse; pharmacist; occupational therapist; |
occupational therapy assistant; physical therapist; physical |
|
therapist assistant; clinical psychologist; physician |
assistant; clinical social worker; social worker; dietitian |
nutritionist; professional counselor; clinical professional |
counselor; and respiratory care practitioner. |
(e) Any person who was issued a temporary reinstatement |
permit by the Department pursuant to a proclamation issued by |
the Secretary or related action by the Director in response to |
the COVID-19 pandemic may continue to practice under his or |
her temporary reinstatement permit if he or she submits an |
application for restoration or reinstatement of his or her |
license to the Department on or before May 11, 2023. Any such |
person may continue to practice under his or her temporary |
reinstatement permit until the Department restores or |
reinstates the license or denies the application, at which |
time the temporary reinstatement permit shall expire. If the |
Department does not restore or reinstate the license or does |
not deny the application by May 11, 2024, the temporary |
reinstatement permit shall expire. If the person holding a |
temporary reinstatement permit does not submit an application |
for restoration or reinstatement to the Department on or |
before May 11, 2023, the temporary reinstatement permit shall |
expire on that date. The Secretary may extend the May 11, 2023 |
deadline under this subsection for an additional 60 days. This |
subsection applies to the following licensed professions: |
physician; registered nurse; practical nurse; advanced |
practice registered nurse; full practice advanced practice |
|
registered nurse; pharmacist; occupational therapist; |
occupational therapy assistant; physical therapist; physical |
therapist assistant; clinical psychologist; physician |
assistant; clinical social worker; social worker; dietitian |
nutritionist; professional counselor; clinical professional |
counselor; and respiratory care practitioner. |
(Source: P.A. 99-227, eff. 8-3-15.) |
Section 10. The Assisted Living and Shared Housing Act is |
amended by changing Sections 40 and 110 as follows:
|
(210 ILCS 9/40)
|
Sec. 40. Probationary licenses. If the applicant has not |
been
previously licensed under this
Act or if the |
establishment is not in operation at the time the application |
is
made and if the Department determines that the applicant |
meets the licensure requirements of this Act, the Department
|
shall
issue a probationary license. A probationary license |
shall be valid for
120 days unless
sooner suspended or |
revoked. Within 30 days prior to the termination of a
|
probationary license,
the Department shall fully and |
completely review the establishment and, if the
establishment
|
meets the applicable requirements for licensure, shall issue a |
license , except that, during a statewide public health |
emergency, as defined in the Illinois Emergency Management |
Agency Act, the Department shall fully and completely review |
|
the establishment to the extent feasible . If the
Department |
finds
that the establishment does not meet the requirements |
for licensure , but has
made substantial
progress toward |
meeting those requirements, the license may be renewed once |
for
a period not to
exceed 120 days from the expiration date of |
the initial probationary license.
|
(Source: P.A. 93-1003, eff. 8-23-04.)
|
(210 ILCS 9/110) |
Sec. 110. Powers and duties of the Department. |
(a) The Department shall conduct an annual unannounced |
on-site visit at
each
assisted living and shared
housing |
establishment to determine compliance with applicable |
licensure
requirements and
standards , except that, during a |
statewide public health emergency, as defined in the Illinois |
Emergency Management Agency Act, the Department shall conduct |
on-site reviews and annual unannounced on-site visits to the |
extent feasible . Additional visits may be conducted without |
prior notice to the
assisted living
or shared housing
|
establishment. |
(b) Upon receipt of information that may indicate the |
failure of the
assisted living or shared housing
establishment |
or a service provider to comply with a provision of this Act,
|
the Department shall
investigate the matter or make |
appropriate referrals to other government
agencies and |
entities having
jurisdiction over the subject matter of the |
|
possible violation. The Department
may also make
referrals to |
any public or private agency that the Department considers
|
available for appropriate
assistance to those involved. The |
Department may oversee and coordinate the
enforcement of State
|
consumer protection policies affecting residents residing in |
an establishment
licensed under this Act. |
(c) The Department shall establish by rule complaint |
receipt,
investigation,
resolution, and involuntary
residency |
termination procedures. Resolution procedures shall provide |
for
on-site review and
evaluation of an assisted living or |
shared housing establishment found to be
in violation of this |
Act
within a specified period of time based on the gravity and |
severity of the
violation and any pervasive
pattern of |
occurrences of the same or similar violations. |
(d) (Blank). |
(e) The Department shall by rule establish penalties and |
sanctions, which
shall include, but need not be limited to,
|
the creation of a schedule of graduated penalties and |
sanctions to include
closure. |
(f) The Department shall by rule establish procedures for |
disclosure of
information to the public, which
shall include, |
but not be limited to, ownership, licensure status, frequency |
of
complaints, disposition of
substantiated complaints, and |
disciplinary actions. |
(g) (Blank). |
(h) Beginning January 1, 2000, the Department shall begin |
|
drafting rules
necessary for the administration
of this Act. |
(Source: P.A. 96-975, eff. 7-2-10.) |
Section 15. The Nursing Home Care Act is amended by |
changing Sections 3-102.2, 3-116, 3-202.5, 3-202.6, 3-206, and |
3-702 as follows:
|
(210 ILCS 45/3-102.2)
|
Sec. 3-102.2. Supported congregate living arrangement |
demonstration. The
Illinois Department may grant no more than |
3 waivers from the requirements of
this Act for facilities |
participating in the supported
congregate living arrangement |
demonstration. A joint waiver request must be
made by an |
applicant and the Department on Aging. If the Department on |
Aging
does not act upon an application within 60 days, the |
applicant may submit a
written waiver request on its own |
behalf. The waiver request must include a
specific program |
plan describing the types of residents to be served and the
|
services that will be provided in the facility. The Department |
shall conduct
an on-site review at each facility annually or |
as often as necessary to
ascertain compliance with the program |
plan , except that, during a statewide public health emergency, |
as defined in the Illinois Emergency Management Agency Act, |
the Department shall conduct on-site reviews and annual |
unannounced on-site visits to the extent feasible . The |
Department may revoke the
waiver if it determines that the |
|
facility is not in compliance with the program
plan. Nothing |
in this Section prohibits the Department from conducting
|
complaint investigations.
|
A facility granted a waiver under this Section is not |
subject to the
Illinois
Health Facilities Planning Act, unless |
it subsequently
applies for a
certificate
of need to convert |
to a nursing facility. A facility applying for conversion
|
shall meet the licensure and
certificate of need requirements |
in effect as of the date of application, and
this provision may |
not be waived.
|
(Source: P.A. 89-530, eff. 7-19-96.)
|
(210 ILCS 45/3-116) (from Ch. 111 1/2, par. 4153-116)
|
Sec. 3-116.
If the applicant has not been previously |
licensed or if the
facility is not in operation at the time |
application is made, the Department
shall issue only a |
probationary license. A probationary license shall be
valid |
for 120 days unless sooner suspended or revoked under Section |
3-119.
Within 30 days prior to the termination of a |
probationary license, the Department
shall fully and |
completely inspect the facility and, if the facility meets
the |
applicable requirements for licensure, shall issue a license |
under Section
3-109 , except that, during a statewide public |
health emergency, as defined in the Illinois Emergency |
Management Agency Act, the Department shall fully and |
completely inspect the establishment within appropriate time |
|
frames to the extent feasible . If the Department finds that |
the facility does not meet the requirements
for licensure but |
has made substantial progress toward meeting those |
requirements,
the license may be renewed once for a period not |
to exceed 120 days from
the expiration date of the initial |
probationary license.
|
(Source: P.A. 81-223.)
|
(210 ILCS 45/3-202.5)
|
Sec. 3-202.5. Facility plan review; fees.
|
(a) Before commencing construction of a new facility or |
specified types of
alteration or additions to an existing long |
term care facility involving
major construction, as defined by |
rule by the Department, with an
estimated cost greater than |
$100,000, architectural
drawings and specifications for the |
facility shall be submitted to the
Department for review and |
approval.
A facility may submit architectural drawings and |
specifications for other
construction projects for Department |
review according to subsection (b) that
shall not be subject |
to fees under subsection (d).
Review of drawings and |
specifications shall be conducted by an employee of the
|
Department meeting the qualifications established by the |
Department of Central
Management Services class specifications |
for such an individual's position or
by a person contracting |
with the Department who meets those class
specifications. |
Final approval of the drawings and specifications for
|
|
compliance with design and construction standards shall be |
obtained from the
Department before the alteration, addition, |
or new construction is begun.
|
(b) The Department shall inform an applicant in writing |
within 10 working
days after receiving drawings and |
specifications and the required fee, if any,
from the |
applicant whether the applicant's submission is complete or
|
incomplete. Failure to provide the applicant with this notice |
within 10
working days shall result in the submission being |
deemed complete for purposes
of initiating the 60-day review |
period under this Section. If the submission
is incomplete, |
the Department shall inform the applicant of the deficiencies
|
with the submission in writing. If the submission is complete |
the required
fee, if any, has been paid,
the Department shall |
approve or disapprove drawings and specifications
submitted to |
the Department no later than 60 days following receipt by the
|
Department. The drawings and specifications shall be of |
sufficient detail, as
provided by Department rule, to
enable |
the Department to
render a determination of compliance with |
design and construction standards
under this Act.
If the |
Department finds that the drawings are not of sufficient |
detail for it
to render a determination of compliance, the |
plans shall be determined to be
incomplete and shall not be |
considered for purposes of initiating the 60-day 60 day
review |
period.
If a submission of drawings and specifications is |
incomplete, the applicant
may submit additional information. |
|
The 60-day review period shall not commence
until the |
Department determines that a submission of drawings and
|
specifications is complete or the submission is deemed |
complete.
If the Department has not approved or disapproved |
the
drawings and specifications within 60 days, the |
construction, major alteration,
or addition shall be deemed |
approved. If the drawings and specifications are
disapproved, |
the Department shall state in writing, with specificity, the
|
reasons for the disapproval. The entity submitting the |
drawings and
specifications may submit additional information |
in response to the written
comments from the Department or |
request a reconsideration of the disapproval.
A final decision |
of approval or disapproval shall be made within 45 days of the
|
receipt of the additional information or reconsideration |
request. If denied,
the Department shall state the specific |
reasons for the denial.
|
(c) The Department shall provide written approval for |
occupancy pursuant
to subsection (g) and shall not issue a |
violation to a facility as a result
of
a licensure or complaint |
survey based upon the facility's physical structure
if:
|
(1) the Department reviewed and approved or deemed |
approved the drawings
and specifications
for compliance |
with design and construction standards;
|
(2) the construction, major alteration, or addition |
was built as
submitted;
|
(3) the law or rules have not been amended since the |
|
original approval;
and
|
(4) the conditions at the facility indicate that there |
is a reasonable
degree of safety provided for the |
residents.
|
(d) The Department shall charge the following fees in |
connection with its
reviews conducted before June 30, 2004 |
under this Section:
|
(1) (Blank).
|
(2) (Blank).
|
(3) If the estimated dollar value of the alteration, |
addition, or new
construction is $100,000 or more but less |
than $500,000, the fee shall be the
greater of $2,400 or |
1.2% of that value.
|
(4) If the estimated dollar value of the alteration, |
addition, or new
construction is $500,000 or more but less |
than $1,000,000, the fee shall be the
greater of $6,000 or |
0.96% of that value.
|
(5) If the estimated dollar value of the alteration, |
addition, or new
construction is $1,000,000 or more but |
less than $5,000,000, the fee shall be
the greater of |
$9,600 or 0.22% of that value.
|
(6) If the estimated dollar value of the alteration, |
addition, or new
construction is $5,000,000 or more, the |
fee shall be
the greater of $11,000 or 0.11% of that value, |
but shall not exceed $40,000.
|
The fees provided in this subsection (d) shall not apply |
|
to major
construction projects involving facility changes that |
are required by
Department rule amendments.
|
The fees provided in this subsection (d) shall also not |
apply to major
construction projects if 51% or more of the |
estimated cost of the project is
attributed to capital |
equipment. For major construction projects where 51% or
more |
of the estimated cost of the project is attributed to capital |
equipment,
the Department shall by rule establish a fee that |
is reasonably related to the
cost of reviewing the project.
|
The Department shall not commence the facility plan review |
process under this
Section until
the applicable fee has been |
paid.
|
(e) All fees received by the Department under this Section |
shall be
deposited into the Health Facility Plan Review Fund, |
a special fund created in
the State Treasury.
All fees paid by |
long-term care facilities under subsection (d) shall be used
|
only to cover the costs relating to the Department's review of |
long-term care
facility projects under this Section.
Moneys |
shall be appropriated from that Fund to the
Department only to |
pay the costs of conducting reviews under this Section or |
under Section 3-202.5 of the ID/DD Community Care Act or |
Section 3-202.5 of the MC/DD Act.
None of the moneys in the |
Health Facility Plan Review Fund shall be used to
reduce the |
amount of General Revenue Fund moneys appropriated to the |
Department
for facility plan reviews conducted pursuant to |
this Section.
|
|
(f)(1) The provisions of this amendatory Act of 1997 |
concerning drawings
and specifications shall apply only to |
drawings and specifications submitted to
the Department on or |
after October 1, 1997.
|
(2) On and after the effective date of this amendatory Act |
of 1997 and
before October 1, 1997, an applicant may submit or |
resubmit drawings and
specifications to the Department and pay |
the fees provided in subsection (d).
If an applicant pays the |
fees provided in subsection (d) under this paragraph
(2), the |
provisions of subsection (b) shall apply with regard to those |
drawings
and specifications.
|
(g) The Department shall conduct an on-site inspection of |
the completed
project no later than 30 days after notification |
from the applicant that the
project has been completed and all |
certifications required by the Department
have been received |
and accepted by the Department , except that, during a |
statewide public health emergency, as defined in the Illinois |
Emergency Management Agency Act, the Department shall conduct |
an on-site inspection of the completed project to the extent |
feasible . The Department shall
provide written approval for |
occupancy to the applicant within 5 working days
of the |
Department's final inspection, provided the applicant has |
demonstrated
substantial compliance as defined by Department |
rule.
Occupancy of new major construction is
prohibited until |
Department approval is received, unless the Department has
not |
acted within the time frames provided in this subsection (g), |
|
in which case
the construction shall be deemed approved. |
Occupancy shall be authorized after any required health |
inspection by the Department has been
conducted.
|
(h) The Department shall establish, by rule, a procedure |
to conduct interim
on-site review of large or complex |
construction projects.
|
(i) The Department shall establish, by rule, an expedited |
process for
emergency repairs or replacement of like |
equipment.
|
(j) Nothing in this Section shall be construed to apply to |
maintenance,
upkeep, or renovation that does not affect the |
structural integrity of the
building, does not add beds or |
services over the number for which the
long-term care facility |
is licensed, and provides a reasonable degree of safety
for |
the residents.
|
(Source: P.A. 98-104, eff. 7-22-13; 99-180, eff. 7-29-15.)
|
(210 ILCS 45/3-202.6) |
Sec. 3-202.6. Department of Veterans' Affairs facility
|
plan review. |
(a) Before commencing construction of a new facility or |
specified types of alteration or additions to an existing |
long-term care facility involving major construction, as |
defined by rule by the Department, with an estimated cost |
greater than $100,000, architectural drawings and |
specifications for the facility shall be submitted to the |
|
Department for review. A facility may submit architectural |
drawings and specifications for other construction projects |
for Department review according to subsection (b) of this |
Section. Review of drawings and specifications shall be |
conducted by an employee of the Department meeting the |
qualifications established by the Department of Central |
Management Services class specifications for such an |
individual's position or by a person contracting with the |
Department who meets those class specifications. |
(b) The Department shall inform an applicant in writing
|
within 15 working days after receiving drawings and |
specifications from the applicant whether the applicant's |
submission is complete or incomplete. Failure to provide the |
applicant with this notice within 15 working days after |
receiving drawings and specifications from the applicant shall |
result in the submission being deemed complete for purposes of |
initiating the 60-working-day review period under this |
Section. If the submission is incomplete, the Department shall |
inform the applicant of the deficiencies with the submission |
in writing. |
If the submission is complete, the Department shall |
approve or disapprove drawings and specifications submitted to |
the
Department no later than 60 working days following receipt |
by the Department. The drawings and specifications shall be of |
sufficient detail, as provided by Department rule, to enable |
the Department to render a determination of compliance with |
|
design and construction standards under this Act. If the |
Department finds that the drawings are not of sufficient |
detail for it to render a determination of compliance, the |
plans shall be determined to be incomplete and shall not be |
considered for purposes of initiating the 60-working-day |
review period. If a submission of drawings and specifications |
is incomplete, the applicant may submit additional |
information. The 60-working-day review period shall not |
commence until the Department determines that a submission of |
drawings and specifications is complete or the submission is |
deemed complete. If the Department has not approved or |
disapproved the drawings and specifications within 60 working |
days after receipt by the Department, the construction, major |
alteration, or addition shall be deemed approved. If the
|
drawings and specifications are disapproved, the Department
|
shall state in writing, with specificity, the reasons for the |
disapproval. The entity submitting the drawings and |
specifications may submit additional information in response |
to the written comments from the Department or request a |
reconsideration of the disapproval. A final decision of |
approval or disapproval shall be made within 45 working days |
after the receipt of the additional information or |
reconsideration request. If denied, the Department shall state |
the specific reasons for the denial. |
(c) The Department shall provide written approval for |
occupancy pursuant to subsection (e) of this Section and shall |
|
not issue a violation to a facility as a result of a licensure |
or complaint survey based upon the facility's physical |
structure if: |
(1) the Department reviewed and approved or is deemed |
to have approved the drawings and specifications for |
compliance with design and construction standards; |
(2) the construction, major alteration, or addition |
was built as submitted; |
(3) the law or rules have not been amended since the |
original approval; and |
(4) the conditions at the facility indicate that there |
is a reasonable degree of safety provided for the |
residents. |
(d) The Department shall not charge a fee in connection |
with its reviews to the Department of Veterans' Affairs. |
(e) The Department shall conduct an on-site inspection of
|
the completed project no later than 45 working days after |
notification from the applicant that the project has been |
completed and all certifications required by the Department |
have been received and accepted by the Department , except |
that, during a statewide public health emergency, as defined |
in the Illinois Emergency Management Agency Act, the |
Department shall conduct an on-site inspection of the |
completed project to the extent feasible . The Department may |
extend this deadline if a federally mandated survey time frame |
takes precedence. The Department shall provide written |
|
approval for occupancy to the applicant within 7 working days |
after the Department's final inspection, provided the |
applicant has demonstrated substantial compliance as defined |
by Department rule. Occupancy of new major construction is |
prohibited until Department approval is received, unless the |
Department has not acted within the time frames provided in |
this subsection (e), in which case the construction shall be |
deemed approved. Occupancy shall be authorized after any |
required health inspection by the Department has been |
conducted. |
(f) The Department shall establish, by rule, an expedited
|
process for emergency repairs or replacement of like |
equipment. |
(g) Nothing in this Section shall be construed to apply to
|
maintenance, upkeep, or renovation that does not affect the |
structural integrity or fire or life safety of the building, |
does not add beds or services over the number for which the |
long-term care facility is licensed, and provides a reasonable |
degree of safety for the residents. |
(h) If the number of licensed facilities increases or the |
number of beds for the currently licensed facilities |
increases, the Department has the right to reassess the |
mandated time frames listed in this Section.
|
(Source: P.A. 99-314, eff. 8-7-15.)
|
(210 ILCS 45/3-206) (from Ch. 111 1/2, par. 4153-206)
|
|
Sec. 3-206.
The Department shall prescribe a curriculum |
for training
nursing assistants, habilitation aides, and child |
care aides.
|
(a) No person, except a volunteer who receives no |
compensation from a
facility and is not included for the |
purpose of meeting any staffing
requirements set forth by the |
Department, shall act as a nursing assistant,
habilitation |
aide, or child care aide in a facility, nor shall any person, |
under any
other title, not licensed, certified, or registered |
to render medical care
by the Department of Financial and |
Professional Regulation, assist with the
personal, medical, or |
nursing care of residents in a facility, unless such
person |
meets the following requirements:
|
(1) Be at least 16 years of age, of temperate habits |
and good moral
character, honest, reliable and |
trustworthy.
|
(2) Be able to speak and understand the English |
language or a language
understood by a substantial |
percentage of the facility's residents.
|
(3) Provide evidence of employment or occupation, if |
any, and residence
for 2 years prior to his present |
employment.
|
(4) Have completed at least 8 years of grade school or |
provide proof of
equivalent knowledge.
|
(5) Begin a current course of training for nursing |
assistants,
habilitation aides, or child care aides, |
|
approved by the Department, within 45 days of initial
|
employment in the capacity of a nursing assistant, |
habilitation aide, or
child care aide
at any facility. |
Such courses of training shall be successfully completed
|
within 120 days of initial employment in the capacity of |
nursing assistant,
habilitation aide, or child care aide |
at a facility. Nursing assistants, habilitation
aides, and |
child care aides who are enrolled in approved courses in |
community
colleges or other educational institutions on a |
term, semester , or trimester
basis, shall be exempt from |
the 120-day completion time limit. During a statewide |
public health emergency, as defined in the Illinois |
Emergency Management Agency Act, all nursing assistants, |
habilitation aides, and child care aides shall, to the |
extent feasible, complete the training. The
Department |
shall adopt rules for such courses of training.
These |
rules shall include procedures for facilities to
carry on |
an approved course of training within the facility. The |
Department shall allow an individual to satisfy the |
supervised clinical experience requirement for placement |
on the Health Care Worker Registry under 77 Ill. Adm. Code |
300.663 through supervised clinical experience at an |
assisted living establishment licensed under the Assisted |
Living and Shared Housing Act. The Department shall adopt |
rules requiring that the Health Care Worker Registry |
include information identifying where an individual on the |
|
Health Care Worker Registry received his or her clinical |
training.
|
The Department may accept comparable training in lieu |
of the 120-hour
course for student nurses, foreign nurses, |
military personnel, or employees of
the Department of |
Human Services.
|
The Department shall accept on-the-job experience in |
lieu of clinical training from any individual who |
participated in the temporary nursing assistant program |
during the COVID-19 pandemic before the end date of the |
temporary nursing assistant program and left the program |
in good standing, and the Department shall notify all |
approved certified nurse assistant training programs in |
the State of this requirement. The individual shall |
receive one hour of credit for every hour employed as a |
temporary nursing assistant, up to 40 total hours, and |
shall be permitted 90 days after the end date of the |
temporary nursing assistant program to enroll in an |
approved certified nursing assistant training program and |
240 days to successfully complete the certified nursing |
assistant training program. Temporary nursing assistants |
who enroll in a certified nursing assistant training |
program within 90 days of the end of the temporary nursing |
assistant program may continue to work as a nursing |
assistant for up to 240 days after enrollment in the |
certified nursing assistant training program. As used in |
|
this Section, "temporary nursing assistant program" means |
the program implemented by the Department of Public Health |
by emergency rule, as listed in 44 Ill. Reg. 7936, |
effective April 21, 2020. |
The facility shall develop and implement procedures, |
which shall be
approved by the Department, for an ongoing |
review process, which shall take
place within the |
facility, for nursing assistants, habilitation aides, and
|
child care aides.
|
At the time of each regularly scheduled licensure |
survey, or at the time
of a complaint investigation, the |
Department may require any nursing
assistant, habilitation |
aide, or child care aide to demonstrate, either through |
written
examination or action, or both, sufficient |
knowledge in all areas of
required training. If such |
knowledge is inadequate the Department shall
require the |
nursing assistant, habilitation aide, or child care aide |
to complete inservice
training and review in the facility |
until the nursing assistant, habilitation
aide, or child |
care aide demonstrates to the Department, either through |
written
examination or action, or both, sufficient |
knowledge in all areas of
required training.
|
(6) Be familiar with and have general skills related |
to resident care.
|
(a-0.5) An educational entity, other than a secondary |
school, conducting a
nursing assistant, habilitation aide, or |
|
child care aide
training program
shall initiate a criminal |
history record check in accordance with the Health Care Worker |
Background Check Act prior to entry of an
individual into the |
training program.
A secondary school may initiate a criminal |
history record check in accordance with the Health Care Worker |
Background Check Act at any time during or after a training |
program.
|
(a-1) Nursing assistants, habilitation aides, or child |
care aides seeking to be included on the Health Care Worker |
Registry under the Health Care Worker Background Check Act on |
or
after January 1, 1996 must authorize the Department of |
Public Health or its
designee
to request a criminal history |
record check in accordance with the Health Care Worker |
Background Check Act and submit all necessary
information. An |
individual may not newly be included on the Health Care Worker |
Registry unless a criminal history record check has been |
conducted with respect to the individual.
|
(b) Persons subject to this Section shall perform their |
duties under the
supervision of a licensed nurse.
|
(c) It is unlawful for any facility to employ any person in |
the capacity
of nursing assistant, habilitation aide, or child |
care aide, or under any other title, not
licensed by the State |
of Illinois to assist in the personal, medical, or
nursing |
care of residents in such facility unless such person has |
complied
with this Section.
|
(d) Proof of compliance by each employee with the |
|
requirements set out
in this Section shall be maintained for |
each such employee by each facility
in the individual |
personnel folder of the employee. Proof of training shall be |
obtained only from the Health Care Worker Registry.
|
(e) Each facility shall obtain access to the Health Care |
Worker Registry's web application, maintain the employment and |
demographic information relating to each employee, and verify |
by the category and type of employment that
each employee |
subject to this Section meets all the requirements of this
|
Section.
|
(f) Any facility that is operated under Section 3-803 |
shall be
exempt
from the requirements of this Section.
|
(g) Each skilled nursing and intermediate care facility |
that
admits
persons who are diagnosed as having Alzheimer's |
disease or related
dementias shall require all nursing |
assistants, habilitation aides, or child
care aides, who did |
not receive 12 hours of training in the care and
treatment of |
such residents during the training required under paragraph
|
(5) of subsection (a), to obtain 12 hours of in-house training |
in the care
and treatment of such residents. If the facility |
does not provide the
training in-house, the training shall be |
obtained from other facilities,
community colleges or other |
educational institutions that have a
recognized course for |
such training. The Department shall, by rule,
establish a |
recognized course for such training. The Department's rules |
shall provide that such
training may be conducted in-house at |
|
each facility subject to the
requirements of this subsection, |
in which case such training shall be
monitored by the |
Department.
|
The Department's rules shall also provide for |
circumstances and procedures
whereby any person who has |
received training that meets
the
requirements of this |
subsection shall not be required to undergo additional
|
training if he or she is transferred to or obtains employment |
at a
different facility or a facility other than a long-term |
care facility but remains continuously employed for pay as a |
nursing assistant,
habilitation aide, or child care aide. |
Individuals
who have performed no nursing or nursing-related |
services
for a period of 24 consecutive months shall be listed |
as "inactive"
and as such do not meet the requirements of this |
Section. Licensed sheltered care facilities
shall be
exempt |
from the requirements of this Section.
|
An individual employed during the COVID-19 pandemic as a |
nursing assistant in accordance with any Executive Orders, |
emergency rules, or policy memoranda related to COVID-19 shall |
be assumed to meet competency standards and may continue to be |
employed as a certified nurse assistant when the pandemic ends |
and the Executive Orders or emergency rules lapse. Such |
individuals shall be listed on the Department's Health Care |
Worker Registry website as "active". |
(Source: P.A. 100-297, eff. 8-24-17; 100-432, eff. 8-25-17; |
100-863, eff. 8-14-18; 101-655, eff. 3-12-21.)
|
|
(210 ILCS 45/3-702) (from Ch. 111 1/2, par. 4153-702)
|
Sec. 3-702.
(a) A person who believes that this Act or a |
rule promulgated
under this Act may have been violated may |
request an investigation. The
request may be submitted to the |
Department in writing, by telephone, by electronic means, or |
by
personal visit. An oral complaint shall be reduced to |
writing by the
Department. The Department shall make |
available, through its website and upon request, information |
regarding the oral and phone intake processes and the list of |
questions that will be asked of the complainant. The |
Department shall request information identifying the
|
complainant, including the name, address , and telephone |
number, to help
enable appropriate follow-up. The Department |
shall act on such complaints
via on-site visits or other |
methods deemed appropriate to handle the
complaints with or |
without such identifying information, as otherwise
provided |
under this Section. The complainant shall be informed that
|
compliance with such request is not required to satisfy the |
procedures for
filing a complaint under this Act. The |
Department must notify complainants that complaints with less |
information provided are far more difficult to respond to and |
investigate.
|
(b) The substance of the complaint shall be provided in |
writing to the
licensee, owner, or administrator no earlier |
than at the commencement of an
on-site inspection of the |
|
facility which takes place pursuant to the complaint.
|
(c) The Department shall not disclose the name of the |
complainant unless
the complainant consents in writing to the |
disclosure or the investigation
results in a judicial |
proceeding, or unless disclosure is essential to the
|
investigation. The complainant shall be given the opportunity |
to withdraw
the complaint before disclosure. Upon the request |
of the complainant, the
Department may permit the complainant |
or a representative of the complainant
to accompany the person |
making the on-site inspection of the facility.
|
(d) Upon receipt of a complaint, the Department shall |
determine whether this
Act or a rule promulgated under this |
Act has been or is being violated. The
Department shall |
investigate all complaints alleging abuse or neglect within
7 |
days after the receipt of the complaint except that complaints |
of abuse
or neglect which indicate that a resident's life or |
safety is in imminent
danger shall be investigated within 24 |
hours after receipt of the
complaint. All other complaints |
shall be investigated within 30 days after
the receipt of the |
complaint , except that, during a statewide public health |
emergency, as defined in the Illinois Emergency Management |
Agency Act, all other complaints shall be investigated within |
appropriate time frames to the extent feasible . The Department |
employees investigating a
complaint shall conduct a brief, |
informal exit conference with the facility
to alert its |
administration of any suspected serious deficiency that poses
|
|
a direct threat to the health, safety , or welfare of a resident |
to enable an
immediate correction for the alleviation or |
elimination of such threat.
Such information and findings |
discussed in the brief exit conference shall
become a part of |
the investigating record but shall not in any way
constitute |
an official or final notice of violation as provided under
|
Section 3-301. All complaints shall be classified as
"an |
invalid report", "a valid report", or "an undetermined
|
report". For any complaint classified as "a valid report", the
|
Department must determine within 30 working days after any |
Department employee enters a facility to begin an on-site |
inspection
if any rule or provision of this Act has been or is |
being violated.
|
(d-1) The Department shall, whenever possible, combine an |
on-site
investigation of a complaint in a facility with other |
inspections in order
to avoid duplication of inspections.
|
(e) In all cases, the Department shall inform the |
complainant of its
findings within 10 days of its |
determination unless otherwise indicated
by the complainant, |
and the complainant may direct the Department to
send a copy of |
such findings to another person. The Department's findings
may |
include comments or documentation provided by either the |
complainant
or the licensee pertaining to the complaint. The |
Department shall also
notify the facility of such findings |
within 10 days of the determination,
but the name of the |
complainant or residents shall not be disclosed in this
notice |
|
to the facility. The notice of such
findings shall include a |
copy of the written determination; the
correction order, if |
any; the warning notice, if any; the inspection
report; or the |
State licensure form on which the violation is listed.
|
(f) A written determination, correction order, or warning |
notice
concerning a complaint, together with the facility's |
response, shall be
available for public inspection, but the |
name of the complainant or
resident shall not be disclosed |
without his consent.
|
(g) A complainant who is dissatisfied with the |
determination or
investigation by the Department may request a |
hearing under Section
3-703. The facility shall be given |
notice of any such
hearing and may participate in the hearing |
as a party. If a facility
requests a hearing under Section |
3-703 which
concerns a matter covered by a complaint, the |
complainant shall be given
notice and may participate in the |
hearing as a party. A request
for a hearing by either a |
complainant or a facility shall be
submitted in writing to the |
Department within 30 days after the mailing
of the |
Department's findings as described in subsection (e) of this
|
Section. Upon receipt of the request the Department shall |
conduct a hearing
as provided under Section 3-703.
|
(g-5) The Department shall conduct an annual review of all |
survey activity from the preceding fiscal year and make a |
report concerning the complaint and survey process. The report |
shall include, but not be limited to: |
|
(1) the total number of complaints received; |
(2) the breakdown of 24-hour, 7-day, and 30-day |
complaints; |
(3) the breakdown of anonymous and non-anonymous |
complaints; |
(4) the number of complaints that were substantiated |
versus unsubstantiated; |
(5) the total number of substantiated complaints that |
were completed in the time frame determined under |
subsection (d); |
(6) the total number of informal dispute resolutions |
requested; |
(7) the total number of informal dispute resolution |
requests approved; |
(8) the total number of informal dispute resolutions |
that were overturned or reduced in severity; |
(9) the total number of nurse surveyors
hired during |
the calendar year; |
(10) the total number of nurse
surveyors who left |
Department employment; |
(11) the average length of tenure for nurse surveyors |
employed by the Department at the time the report is |
created; |
(12) the total number of times the Department imposed |
discretionary denial of payment within 15 days of notice |
and within 2 days of notice as well as the number of times |
|
the discretionary denial of payment took effect; and |
(13) any other complaint information requested by the |
Long-Term Care Facility Advisory Board created under |
Section 2-204 of this Act or the Illinois Long-Term Care |
Council created under Section 4.04a of the Illinois Act on |
the Aging. |
This report shall be provided to the Long-Term Care |
Facility Advisory Board, the Illinois Long-Term Care Council, |
and the General Assembly. The Long-Term Care Facility Advisory |
Board and the Illinois Long-Term Care Council shall review the |
report and suggest any changes deemed necessary to the |
Department for review and action, including how to investigate |
and substantiate anonymous complaints. |
(h) Any person who knowingly transmits a false report to |
the
Department commits the offense of disorderly conduct under |
subsection
(a)(8) of Section 26-1 of the Criminal Code of |
2012.
|
(Source: P.A. 102-432, eff. 8-20-21; 102-947, eff. 1-1-23; |
revised 12-9-22.)
|
Section 20. The MC/DD Act is amended by changing Sections |
3-116, 3-202.5, and 3-702 as follows: |
(210 ILCS 46/3-116)
|
Sec. 3-116. Probationary license. If the applicant has not |
been previously licensed or if the facility is not in |
|
operation at the time application is made, the Department |
shall issue only a probationary license. A probationary |
license shall be valid for 120 days unless sooner suspended or |
revoked under Section 3-119. Within 30 days prior to the |
termination of a probationary license, the Department shall |
fully and completely inspect the facility and, if the facility |
meets the applicable requirements for licensure, shall issue a |
license under Section 3-109 , except that, during a statewide |
public health emergency, as defined in the Illinois Emergency |
Management Agency Act, the Department shall inspect facilities |
within an appropriate time frame to the extent feasible . If |
the Department finds that the facility does not meet the |
requirements for licensure but has made substantial progress |
toward meeting those requirements, the license may be renewed |
once for a period not to exceed 120 days from the expiration |
date of the initial probationary license.
|
(Source: P.A. 99-180, eff. 7-29-15.) |
(210 ILCS 46/3-202.5)
|
Sec. 3-202.5. Facility plan review; fees. |
(a) Before commencing construction of a new facility or |
specified types of alteration or additions to an existing |
facility involving major construction, as defined by rule by |
the Department, with an estimated cost greater than $100,000, |
architectural drawings and specifications for the facility |
shall be submitted to the Department for review and approval. |
|
A facility may submit architectural drawings and |
specifications for other construction projects for Department |
review according to subsection (b) that shall not be subject |
to fees under subsection (d). Review of drawings and |
specifications shall be conducted by an employee of the |
Department meeting the qualifications established by the |
Department of Central Management Services class specifications |
for such an individual's position or by a person contracting |
with the Department who meets those class specifications. |
Final approval of the drawings and specifications for |
compliance with design and construction standards shall be |
obtained from the Department before the alteration, addition, |
or new construction is begun. |
(b) The Department shall inform an applicant in writing |
within 10 working days after receiving drawings and |
specifications and the required fee, if any, from the |
applicant whether the applicant's submission is complete or |
incomplete. Failure to provide the applicant with this notice |
within 10 working days shall result in the submission being |
deemed complete for purposes of initiating the 60-day 60 day |
review period under this Section. If the submission is |
incomplete, the Department shall inform the applicant of the |
deficiencies with the submission in writing. If the submission |
is complete the required fee, if any, has been paid, the |
Department shall approve or disapprove drawings and |
specifications submitted to the Department no later than 60 |
|
days following receipt by the Department. The drawings and |
specifications shall be of sufficient detail, as provided by |
Department rule, to enable the Department to render a |
determination of compliance with design and construction |
standards under this Act. If the Department finds that the |
drawings are not of sufficient detail for it to render a |
determination of compliance, the plans shall be determined to |
be incomplete and shall not be considered for purposes of |
initiating the 60 day review period. If a submission of |
drawings and specifications is incomplete, the applicant may |
submit additional information. The 60 day review period shall |
not commence until the Department determines that a submission |
of drawings and specifications is complete or the submission |
is deemed complete. If the Department has not approved or |
disapproved the drawings and specifications within 60 days, |
the construction, major alteration, or addition shall be |
deemed approved. If the drawings and specifications are |
disapproved, the Department shall state in writing, with |
specificity, the reasons for the disapproval. The entity |
submitting the drawings and specifications may submit |
additional information in response to the written comments |
from the Department or request a reconsideration of the |
disapproval. A final decision of approval or disapproval shall |
be made within 45 days of the receipt of the additional |
information or reconsideration request. If denied, the |
Department shall state the specific reasons for the denial. |
|
(c) The Department shall provide written approval for |
occupancy pursuant to subsection (g) and shall not issue a |
violation to a facility as a result of a licensure or complaint |
survey based upon the facility's physical structure if: |
(1) the Department reviewed and approved or deemed
|
approved the drawings and specifications for compliance |
with design and construction standards; |
(2) the construction, major alteration, or addition
|
was built as submitted; |
(3) the law or rules have not been amended since the
|
original approval; and |
(4) the conditions at the facility indicate that
there |
is a reasonable degree of safety provided for the |
residents. |
(d) (Blank). |
(e) All fees received by the Department under this Section |
shall be deposited into the Health Facility Plan Review Fund, |
a special fund created in the State Treasury. Moneys shall be |
appropriated from that Fund to the Department only to pay the |
costs of conducting reviews under this Section, under Section |
3-202.5 of the Nursing Home Care Act, or under Section 3-202.5 |
of the ID/DD Community Care Act. None of the moneys in the |
Health Facility Plan Review Fund shall be used to reduce the |
amount of General Revenue Fund moneys appropriated to the |
Department for facility plan reviews conducted pursuant to |
this Section. |
|
(f) (Blank). |
(g) The Department shall conduct an on site inspection of |
the completed project no later than 30 days after notification |
from the applicant that the project has been completed and all |
certifications required by the Department have been received |
and accepted by the Department , except that, during a |
statewide public health emergency, as defined in the Illinois |
Emergency Management Agency Act, the Department shall conduct |
an on-site inspection to the extent feasible . The Department |
shall provide written approval for occupancy to the applicant |
within 5 working days of the Department's final inspection, |
provided the applicant has demonstrated substantial compliance |
as defined by Department rule. Occupancy of new major |
construction is prohibited until Department approval is |
received, unless the Department has not acted within the time |
frames provided in this subsection (g), in which case the |
construction shall be deemed approved. Occupancy shall be |
authorized after any required health inspection by the |
Department has been conducted. |
(h) The Department shall establish, by rule, a procedure |
to conduct interim on site review of large or complex |
construction projects. |
(i) The Department shall establish, by rule, an expedited |
process for emergency repairs or replacement of like |
equipment. |
(j) Nothing in this Section shall be construed to apply to |
|
maintenance, upkeep, or renovation that does not affect the |
structural integrity of the building, does not add beds or |
services over the number for which the facility is licensed, |
and provides a reasonable degree of safety for the residents.
|
(Source: P.A. 99-180, eff. 7-29-15.) |
(210 ILCS 46/3-702)
|
Sec. 3-702. Request for investigation of violation. |
(a) A person who believes that this Act or a rule |
promulgated under this Act may have been violated may request |
an investigation. The request may be submitted to the |
Department in writing, by telephone, by electronic means, or |
by personal visit. An oral complaint shall be reduced to |
writing by the Department. The Department shall make |
available, through
its website and upon request, information |
regarding the oral
and phone intake processes and the list of |
questions that will
be asked of the complainant. The |
Department shall request information identifying the |
complainant, including the name, address and telephone number, |
to help enable appropriate follow up. The Department shall act |
on such complaints via on-site visits or other methods deemed |
appropriate to handle the complaints with or without such |
identifying information, as otherwise provided under this |
Section. The complainant shall be informed that compliance |
with such request is not required to satisfy the procedures |
for filing a complaint under this Act. The Department must |
|
notify complainants that complaints with less information |
provided are far more difficult to respond to and investigate. |
(b) The substance of the complaint shall be provided in |
writing to the licensee, owner or administrator no earlier |
than at the commencement of an on-site inspection of the |
facility which takes place pursuant to the complaint. |
(c) The Department shall not disclose the name of the |
complainant unless the complainant consents in writing to the |
disclosure or the investigation results in a judicial |
proceeding, or unless disclosure is essential to the |
investigation. The complainant shall be given the opportunity |
to withdraw the complaint before disclosure. Upon the request |
of the complainant, the Department may permit the complainant |
or a representative of the complainant to accompany the person |
making the on-site inspection of the facility. |
(d) Upon receipt of a complaint, the Department shall |
determine whether this Act or a rule promulgated under this |
Act has been or is being violated. The Department shall |
investigate all complaints alleging abuse or neglect within 7 |
days after the receipt of the complaint except that complaints |
of abuse or neglect which indicate that a resident's life or |
safety is in imminent danger shall be investigated within 24 |
hours after receipt of the complaint. All other complaints |
shall be investigated within 30 days after the receipt of the |
complaint , except that, during a statewide public health |
emergency, as defined in the Illinois Emergency Management |
|
Agency Act, all other complaints shall be investigated within |
an appropriate time frame to the extent feasible . The |
Department employees investigating a complaint shall conduct a |
brief, informal exit conference with the facility to alert its |
administration of any suspected serious deficiency that poses |
a direct threat to the health, safety or welfare of a resident |
to enable an immediate correction for the alleviation or |
elimination of such threat. Such information and findings |
discussed in the brief exit conference shall become a part of |
the investigating record but shall not in any way constitute |
an official or final notice of violation as provided under |
Section 3-301. All complaints shall be classified as "an |
invalid report", "a valid report", or "an undetermined |
report". For any complaint classified as "a valid report", the |
Department must determine within 30 working days if any rule |
or provision of this Act has been or is being violated. |
(d-1) The Department shall, whenever possible, combine an |
on site investigation of a complaint in a facility with other |
inspections in order to avoid duplication of inspections. |
(e) In all cases, the Department shall inform the |
complainant of its findings within 10 days of its |
determination unless otherwise indicated by the complainant, |
and the complainant may direct the Department to send a copy of |
such findings to another person. The Department's findings may |
include comments or documentation provided by either the |
complainant or the licensee pertaining to the complaint. The |
|
Department shall also notify the facility of such findings |
within 10 days of the determination, but the name of the |
complainant or residents shall not be disclosed in this notice |
to the facility. The notice of such findings shall include a |
copy of the written determination; the correction order, if |
any; the warning notice, if any; the inspection report; or the |
State licensure form on which the violation is listed. |
(f) A written determination, correction order, or warning |
notice concerning a complaint, together with the facility's |
response, shall be available for public inspection, but the |
name of the complainant or resident shall not be disclosed |
without his or her consent. |
(g) A complainant who is dissatisfied with the |
determination or investigation by the Department may request a |
hearing under Section 3-703. The facility shall be given |
notice of any such hearing and may participate in the hearing |
as a party. If a facility requests a hearing under Section |
3-703 which concerns a matter covered by a complaint, the |
complainant shall be given notice and may participate in the |
hearing as a party. A request for a hearing by either a |
complainant or a facility shall be submitted in writing to the |
Department within 30 days after the mailing of the |
Department's findings as described in subsection (e) of this |
Section. Upon receipt of the request the Department shall |
conduct a hearing as provided under Section 3-703. |
(g-5) The Department shall conduct an annual review and
|
|
make a report concerning the complaint process that includes
|
the number of complaints received, the breakdown of anonymous
|
and non-anonymous complaints and whether the complaints were
|
substantiated or not, the total number of substantiated
|
complaints, and any other complaint information requested by
|
the DD Facility Advisory Board. This report shall be provided |
to the DD Facility Advisory Board. The DD Facility Advisory |
Board shall review the report and suggest any changes deemed |
necessary to the Department for review and action, including |
how to investigate and substantiate anonymous complaints. |
(h) Any person who knowingly transmits a false report to |
the Department commits the offense of disorderly conduct under |
subsection (a)(8) of Section 26-1 of the Criminal Code of |
2012.
|
(Source: P.A. 99-180, eff. 7-29-15.) |
Section 25. The ID/DD Community Care Act is amended by |
changing Sections 3-116, 3-206, and 3-702 as follows: |
(210 ILCS 47/3-116)
|
Sec. 3-116. Probationary license. If the applicant has not |
been previously licensed or if the facility is not in |
operation at the time application is made, the Department |
shall issue only a probationary license. A probationary |
license shall be valid for 120 days unless sooner suspended or |
revoked under Section 3-119. Within 30 days prior to the |
|
termination of a probationary license, the Department shall |
fully and completely inspect the facility and, if the facility |
meets the applicable requirements for licensure, shall issue a |
license under Section 3-109 except that, during a statewide |
public health emergency, as defined in the Illinois Emergency |
Management Agency Act, the Department shall inspect facilities |
within an appropriate time frame to the extent feasible . If |
the Department finds that the facility does not meet the |
requirements for licensure but has made substantial progress |
toward meeting those requirements, the license may be renewed |
once for a period not to exceed 120 days from the expiration |
date of the initial probationary license.
|
(Source: P.A. 96-339, eff. 7-1-10 .) |
(210 ILCS 47/3-206)
|
Sec. 3-206. Curriculum for training nursing assistants and |
aides. The Department shall prescribe a curriculum for |
training nursing assistants, habilitation aides, and child |
care aides. |
(a) No person, except a volunteer who receives no |
compensation from a facility and is not included for the |
purpose of meeting any staffing requirements set forth by the |
Department, shall act as a nursing assistant, habilitation |
aide, or child care aide in a facility, nor shall any person, |
under any other title, not licensed, certified, or registered |
to render medical care by the Department of Financial and |
|
Professional Regulation, assist with the personal, medical, or |
nursing care of residents in a facility, unless such person |
meets the following requirements: |
(1) Be at least 16 years of age, of temperate habits
|
and good moral character, honest, reliable and |
trustworthy. |
(2) Be able to speak and understand the English
|
language or a language understood by a substantial |
percentage of the facility's residents. |
(3) Provide evidence of employment or occupation, if
|
any, and residence for 2 years prior to his or her present |
employment. |
(4) Have completed at least 8 years of grade school
or |
provide proof of equivalent knowledge. |
(5) Begin a current course of training for nursing
|
assistants, habilitation aides, or child care aides, |
approved by the Department, within 45 days of initial |
employment in the capacity of a nursing assistant, |
habilitation aide, or child care aide at any facility. |
Such courses of training shall be successfully completed |
within 120 days of initial employment in the capacity of |
nursing assistant, habilitation aide, or child care aide |
at a facility , except that, during a statewide public |
health emergency, as defined in the Illinois Emergency |
Management Agency Act, training shall be completed to the |
extent feasible . Nursing assistants, habilitation aides, |
|
and child care aides who are enrolled in approved courses |
in community colleges or other educational institutions on |
a term, semester or trimester basis, shall be exempt from |
the 120-day completion time limit. The Department shall |
adopt rules for such courses of training. These rules |
shall include procedures for facilities to carry on an |
approved course of training within the facility. |
The Department may accept comparable training in
lieu |
of the 120-hour course for student nurses, foreign nurses, |
military personnel, or employees of the Department of |
Human Services. |
The facility shall develop and implement procedures,
|
which shall be approved by the Department, for an ongoing |
review process, which shall take place within the |
facility, for nursing assistants, habilitation aides, and |
child care aides. |
At the time of each regularly scheduled licensure
|
survey, or at the time of a complaint investigation, the |
Department may require any nursing assistant, habilitation |
aide, or child care aide to demonstrate, either through |
written examination or action, or both, sufficient |
knowledge in all areas of required training. If such |
knowledge is inadequate the Department shall require the |
nursing assistant, habilitation aide, or child care aide |
to complete inservice training and review in the facility |
until the nursing assistant, habilitation aide, or child |
|
care aide demonstrates to the Department, either through |
written examination or action, or both, sufficient |
knowledge in all areas of required training; and |
(6) Be familiar with and have general skills related
|
to resident care. |
(a-0.5) An educational entity, other than a secondary |
school, conducting a nursing assistant, habilitation aide, or |
child care aide training program shall initiate a criminal |
history record check in accordance with the Health Care Worker |
Background Check Act prior to entry of an individual into the |
training program. A secondary school may initiate a criminal |
history record check in accordance with the Health Care Worker |
Background Check Act at any time during or after a training |
program. |
(a-1) Nursing assistants, habilitation aides, or child |
care aides seeking to be included on the Health Care Worker |
Registry under the Health Care Worker Background Check Act |
must authorize the Department of Public Health or its designee |
to request a criminal history record check in accordance with |
the Health Care Worker Background Check Act and submit all |
necessary information. An individual may not newly be included |
on the Health Care Worker Registry unless a criminal history |
record check has been conducted with respect to the |
individual. |
(b) Persons subject to this Section shall perform their |
duties under the supervision of a licensed nurse or other |
|
appropriately trained, licensed, or certified personnel. |
(c) It is unlawful for any facility to employ any person in |
the capacity of nursing assistant, habilitation aide, or child |
care aide, or under any other title, not licensed by the State |
of Illinois to assist in the personal, medical, or nursing |
care of residents in such facility unless such person has |
complied with this Section. |
(d) Proof of compliance by each employee with the |
requirements set out in this Section shall be maintained for |
each such employee by each facility in the individual |
personnel folder of the employee. Proof of training shall be |
obtained only from the Health Care Worker Registry. |
(e) Each facility shall obtain access to the Health Care |
Worker Registry's web application, maintain the employment and |
demographic information relating to each employee, and verify |
by the category and type of employment that each employee |
subject to this Section meets all the requirements of this |
Section. |
(f) Any facility that is operated under Section 3-803 |
shall be exempt from the requirements of this Section. |
(g) Each skilled nursing and intermediate care facility |
that admits persons who are diagnosed as having Alzheimer's |
disease or related dementias shall require all nursing |
assistants, habilitation aides, or child care aides, who did |
not receive 12 hours of training in the care and treatment of |
such residents during the training required under paragraph |
|
(5) of subsection (a), to obtain 12 hours of in house training |
in the care and treatment of such residents. If the facility |
does not provide the training in house, the training shall be |
obtained from other facilities, community colleges or other |
educational institutions that have a recognized course for |
such training. The Department shall, by rule, establish a |
recognized course for such training. |
The Department's rules shall provide that such training |
may be conducted in house at each facility subject to the |
requirements of this subsection, in which case such training |
shall be monitored by the Department.
The Department's rules |
shall also provide for circumstances and procedures whereby |
any person who has received training that meets the |
requirements of this subsection shall not be required to |
undergo additional training if he or she is transferred to or |
obtains employment at a different facility or a facility other |
than those licensed under this Act but remains continuously |
employed as a nursing assistant, habilitation aide, or child |
care aide. Individuals who have performed no nursing, |
nursing-related services, or habilitation services for a |
period of 24 consecutive months shall be listed as inactive |
and as such do not meet the requirements of this Section. |
Licensed sheltered care facilities shall be exempt from the |
requirements of this Section.
|
(Source: P.A. 100-432, eff. 8-25-17.) |
|
(210 ILCS 47/3-702)
|
Sec. 3-702. Request for investigation of violation. |
(a) A person who believes that this Act or a rule |
promulgated under this Act may have been violated may request |
an investigation. The request may be submitted to the |
Department in writing, by telephone, by electronic means, or |
by personal visit. An oral complaint shall be reduced to |
writing by the Department. The Department shall make |
available, through
its website and upon request, information |
regarding the oral
and phone intake processes and the list of |
questions that will
be asked of the complainant. The |
Department shall request information identifying the |
complainant, including the name, address and telephone number, |
to help enable appropriate follow up. The Department shall act |
on such complaints via on-site visits or other methods deemed |
appropriate to handle the complaints with or without such |
identifying information, as otherwise provided under this |
Section. The complainant shall be informed that compliance |
with such request is not required to satisfy the procedures |
for filing a complaint under this Act. The Department must |
notify complainants that complaints with less information |
provided are far more difficult to respond to and investigate. |
(b) The substance of the complaint shall be provided in |
writing to the licensee, owner or administrator no earlier |
than at the commencement of an on-site inspection of the |
facility which takes place pursuant to the complaint. |
|
(c) The Department shall not disclose the name of the |
complainant unless the complainant consents in writing to the |
disclosure or the investigation results in a judicial |
proceeding, or unless disclosure is essential to the |
investigation. The complainant shall be given the opportunity |
to withdraw the complaint before disclosure. Upon the request |
of the complainant, the Department may permit the complainant |
or a representative of the complainant to accompany the person |
making the on-site inspection of the facility. |
(d) Upon receipt of a complaint, the Department shall |
determine whether this Act or a rule promulgated under this |
Act has been or is being violated. The Department shall |
investigate all complaints alleging abuse or neglect within 7 |
days after the receipt of the complaint except that complaints |
of abuse or neglect which indicate that a resident's life or |
safety is in imminent danger shall be investigated within 24 |
hours after receipt of the complaint. All other complaints |
shall be investigated within 30 days after the receipt of the |
complaint , except that, during a statewide public health |
emergency, as defined in the Illinois Emergency Management |
Agency Act, all other complaints shall be investigated within |
an appropriate time frame to the extent feasible . The |
Department employees investigating a complaint shall conduct a |
brief, informal exit conference with the facility to alert its |
administration of any suspected serious deficiency that poses |
a direct threat to the health, safety or welfare of a resident |
|
to enable an immediate correction for the alleviation or |
elimination of such threat. Such information and findings |
discussed in the brief exit conference shall become a part of |
the investigating record but shall not in any way constitute |
an official or final notice of violation as provided under |
Section 3-301. All complaints shall be classified as "an |
invalid report", "a valid report", or "an undetermined |
report". For any complaint classified as "a valid report", the |
Department must determine within 30 working days if any rule |
or provision of this Act has been or is being violated. |
(d-1) The Department shall, whenever possible, combine an |
on site investigation of a complaint in a facility with other |
inspections in order to avoid duplication of inspections. |
(e) In all cases, the Department shall inform the |
complainant of its findings within 10 days of its |
determination unless otherwise indicated by the complainant, |
and the complainant may direct the Department to send a copy of |
such findings to another person. The Department's findings may |
include comments or documentation provided by either the |
complainant or the licensee pertaining to the complaint. The |
Department shall also notify the facility of such findings |
within 10 days of the determination, but the name of the |
complainant or residents shall not be disclosed in this notice |
to the facility. The notice of such findings shall include a |
copy of the written determination; the correction order, if |
any; the warning notice, if any; the inspection report; or the |
|
State licensure form on which the violation is listed. |
(f) A written determination, correction order, or warning |
notice concerning a complaint, together with the facility's |
response, shall be available for public inspection, but the |
name of the complainant or resident shall not be disclosed |
without his or her consent. |
(g) A complainant who is dissatisfied with the |
determination or investigation by the Department may request a |
hearing under Section 3-703. The facility shall be given |
notice of any such hearing and may participate in the hearing |
as a party. If a facility requests a hearing under Section |
3-703 which concerns a matter covered by a complaint, the |
complainant shall be given notice and may participate in the |
hearing as a party. A request for a hearing by either a |
complainant or a facility shall be submitted in writing to the |
Department within 30 days after the mailing of the |
Department's findings as described in subsection (e) of this |
Section. Upon receipt of the request the Department shall |
conduct a hearing as provided under Section 3-703. |
(g-5) The Department shall conduct an annual review and
|
make a report concerning the complaint process that includes
|
the number of complaints received, the breakdown of anonymous
|
and non-anonymous complaints and whether the complaints were
|
substantiated or not, the total number of substantiated
|
complaints, and any other complaint information requested by
|
the DD Facility Advisory Board. This report shall be provided |
|
to the DD Facility Advisory Board. The DD Facility Advisory |
Board shall review the report and suggest any changes deemed |
necessary to the Department for review and action, including |
how to investigate and substantiate anonymous complaints. |
(h) Any person who knowingly transmits a false report to |
the Department commits the offense of disorderly conduct under |
subsection (a)(8) of Section 26-1 of the Criminal Code of |
2012.
|
(Source: P.A. 97-1150, eff. 1-25-13; 98-988, eff. 8-18-14.) |
Section 30. The Specialized Mental Health Rehabilitation |
Act of 2013 is amended by changing Section 4-105 as follows: |
(210 ILCS 49/4-105)
|
Sec. 4-105. Provisional licensure duration. A provisional |
license shall be valid upon fulfilling the requirements |
established by the Department by emergency rule. The license |
shall remain valid as long as a facility remains in compliance |
with the licensure provisions established in rule. Provisional |
licenses issued upon initial licensure as a specialized mental |
health rehabilitation facility shall expire at the end of a |
3-year period, which commences on the date the provisional |
license is issued. Issuance of a provisional license for any |
reason other than initial licensure (including, but not |
limited to, change of ownership, location, number of beds, or |
services) shall not extend the maximum 3-year period, at the |
|
end of which a facility must be licensed pursuant to Section |
4-201. An extension for 120 days may be granted if requested |
and approved by the Department. Notwithstanding any other |
provision of this Act or the Specialized Mental Health |
Rehabilitation Facilities Code, 77 Ill. Adm. Admin. Code 380, |
to the contrary, if a facility has received notice from the |
Department that its application for provisional licensure to |
provide recovery and rehabilitation services has been accepted |
as complete and the facility has attested in writing to the |
Department that it will comply with the staff training plan |
approved by the Division of Mental Health, then a provisional |
license for recovery and rehabilitation services shall be |
issued to the facility within 60 days after the Department |
determines that the facility is in compliance with the |
requirements of the Life Safety Code in accordance with |
Section 4-104.5 of this Act.
|
(Source: P.A. 99-712, eff. 8-5-16; 100-365, eff. 8-25-17; |
revised 2-28-22.) |
Section 35. The Illinois Insurance Code is amended by |
adding Section 356z.61 as follows: |
(215 ILCS 5/356z.61 new) |
Sec. 356z.61. Coverage of pharmacy testing, screening, |
vaccinations, and treatment. |
A group or individual policy of accident and health |
|
insurance or a managed care plan that is amended, delivered, |
issued, or renewed on or after January 1, 2025 shall provide |
coverage for health care or patient care services provided by |
a pharmacist if: |
(1) the pharmacist meets the requirements and scope of |
practice described in paragraph (15), (16), or (17) of |
subsection (d) of Section 3 of the Pharmacy Practice Act; |
(2) the health plan provides coverage for the same |
service provided by a licensed physician, an advanced |
practice registered nurse, or a physician assistant; |
(3) the pharmacist is included in the health benefit |
plan's network of participating providers; and |
(4) reimbursement has been successfully negotiated in |
good faith between the pharmacist and the health plan. |
Section 45. The Medical Practice Act of 1987 is amended by |
changing Sections 2 and 54.2 as follows:
|
(225 ILCS 60/2) (from Ch. 111, par. 4400-2)
|
(Section scheduled to be repealed on January 1, 2027)
|
Sec. 2. Definitions. For purposes of this Act, the
|
following definitions shall have the following meanings,
|
except where the context requires otherwise:
|
"Act" means the Medical Practice Act of 1987.
|
"Address of record" means the designated address recorded |
by the Department in the applicant's or licensee's application |
|
file or license file as maintained by the Department's |
licensure maintenance unit. |
"Chiropractic physician" means a person licensed to treat |
human ailments without the use of drugs and without operative |
surgery. Nothing in this Act shall be construed to prohibit a |
chiropractic physician from providing advice regarding the use |
of non-prescription products or from administering atmospheric |
oxygen. Nothing in this Act shall be construed to authorize a |
chiropractic physician to prescribe drugs. |
"Department" means the Department of Financial and |
Professional Regulation.
|
"Disciplinary action" means revocation,
suspension, |
probation, supervision, practice modification,
reprimand, |
required education, fines or any other action
taken by the |
Department against a person holding a license.
|
"Email address of record" means the designated email |
address recorded by the Department in the applicant's |
application file or the licensee's license file, as maintained |
by the Department's licensure maintenance unit. |
"Final determination" means the governing body's
final |
action taken under the procedure followed by a health
care |
institution, or professional association or society,
against |
any person licensed under the Act in accordance with
the |
bylaws or rules and regulations of such health care
|
institution, or professional association or society.
|
"Fund" means the Illinois State Medical Disciplinary Fund.
|
|
"Impaired" means the inability to practice
medicine with |
reasonable skill and safety due to physical or
mental |
disabilities as evidenced by a written determination
or |
written consent based on clinical evidence including
|
deterioration through the aging process or loss of motor
|
skill, or abuse of drugs or alcohol, of sufficient degree to
|
diminish a person's ability to deliver competent patient
care.
|
"International medical graduate" means a medical graduate |
(i) who has been trained in a country other than the United |
States; (ii) whose education has been certified by the |
Educational Commission for Foreign Medical Graduates; (iii) |
who has passed Step 1, Step 2 Clinical Knowledge, and Step 3 of |
the United States Medical Licensing Examination as required by |
this Act; (iv) who maintains an unencumbered license from |
another country; and (v) who is not licensed to practice |
medicine in any state or territory of the United States. |
"Medical Board" means the Illinois State Medical Board. |
"Physician" means a person licensed under the
Medical |
Practice Act to practice medicine in all of its
branches or a |
chiropractic physician.
|
"Professional association" means an association or
society |
of persons licensed under this Act, and operating
within the |
State of Illinois, including but not limited to,
medical |
societies, osteopathic organizations, and
chiropractic |
organizations, but this term shall not be
deemed to include |
hospital medical staffs.
|
|
"Program of care, counseling, or treatment" means
a |
written schedule of organized treatment, care, counseling,
|
activities, or education, satisfactory to the Medical
Board, |
designed for the purpose of restoring an impaired
person to a |
condition whereby the impaired person can
practice medicine |
with reasonable skill and safety of a
sufficient degree to |
deliver competent patient care.
|
"Reinstate" means to change the status of a license or |
permit from inactive or nonrenewed status to active status. |
"Restore" means to remove an encumbrance from a license |
due to probation, suspension, or revocation. |
"Secretary" means the Secretary of Financial and |
Professional Regulation. |
(Source: P.A. 102-20, eff. 1-1-22; 102-1117, eff. 1-13-23.)
|
(225 ILCS 60/54.2) |
(Section scheduled to be repealed on January 1, 2027) |
Sec. 54.2. Physician delegation of authority. |
(a) Nothing in this Act shall be construed to limit the |
delegation of patient care tasks or duties by a physician, to a |
licensed practical nurse, a registered professional nurse, or |
other licensed person practicing within the scope of his or |
her individual licensing Act. Delegation by a physician |
licensed to practice medicine in all its branches to physician |
assistants or advanced practice registered nurses is also |
addressed in Section 54.5 of this Act. No physician may |
|
delegate any patient care task or duty that is statutorily or |
by rule mandated to be performed by a physician. |
(b) In an office or practice setting and within a |
physician-patient relationship, a physician may delegate |
patient care tasks or duties to an unlicensed person who |
possesses appropriate training and experience provided a |
health care professional, who is practicing within the scope |
of such licensed professional's individual licensing Act, is |
on site to provide assistance. |
(c) Any such patient care task or duty delegated to a |
licensed or unlicensed person must be within the scope of |
practice, education, training, or experience of the delegating |
physician and within the context of a physician-patient |
relationship. |
(d) Nothing in this Section shall be construed to affect |
referrals for professional services required by law. |
(e) The Department shall have the authority to promulgate |
rules concerning a physician's delegation, including but not |
limited to, the use of light emitting devices for patient care |
or treatment.
|
(f) Nothing in this Act shall be construed to limit the |
method of delegation that may be authorized by any means, |
including, but not limited to, oral, written, electronic, |
standing orders, protocols, guidelines, or verbal orders. |
(g) A physician licensed to practice medicine in all of |
its branches under this Act may delegate any and all authority |
|
prescribed to him or her by law to international medical |
graduate physicians, so long as the tasks or duties are within |
the scope of practice, education, training, or experience of |
the delegating physician who is on site to provide assistance. |
An international medical graduate working in Illinois pursuant |
to this subsection is subject to all statutory and regulatory |
requirements of this Act, as applicable, relating to the |
standards of care. An international medical graduate physician |
is limited to providing treatment under the supervision of a |
physician licensed to practice medicine in all of its |
branches. The supervising physician or employer must keep |
record of and make available upon request by the Department |
the following: (1) evidence of education certified by the |
Educational Commission for Foreign Medical Graduates; (2) |
evidence of passage of Step 1, Step 2 Clinical Knowledge, and |
Step 3 of the United States Medical Licensing Examination as |
required by this Act; and (3) evidence of an unencumbered |
license from another country. This subsection does not apply |
to any international medical graduate whose license as a |
physician is revoked, suspended, or otherwise encumbered. |
(Source: P.A. 100-513, eff. 1-1-18 .) |
Section 50. The Pharmacy Practice Act is amended by |
changing Section 3 and by adding Section 9.6 as follows:
|
(225 ILCS 85/3)
|
|
(Section scheduled to be repealed on January 1, 2028)
|
Sec. 3. Definitions. For the purpose of this Act, except |
where otherwise
limited therein:
|
(a) "Pharmacy" or "drugstore" means and includes every |
store, shop,
pharmacy department, or other place where |
pharmacist
care is
provided
by a pharmacist (1) where drugs, |
medicines, or poisons are
dispensed, sold or
offered for sale |
at retail, or displayed for sale at retail; or
(2)
where
|
prescriptions of physicians, dentists, advanced practice |
registered nurses, physician assistants, veterinarians, |
podiatric physicians, or
optometrists, within the limits of |
their
licenses, are
compounded, filled, or dispensed; or (3) |
which has upon it or
displayed within
it, or affixed to or used |
in connection with it, a sign bearing the word or
words |
"Pharmacist", "Druggist", "Pharmacy", "Pharmaceutical
Care", |
"Apothecary", "Drugstore",
"Medicine Store", "Prescriptions", |
"Drugs", "Dispensary", "Medicines", or any word
or words of |
similar or like import, either in the English language
or any |
other language; or (4) where the characteristic prescription
|
sign (Rx) or similar design is exhibited; or (5) any store, or
|
shop,
or other place with respect to which any of the above |
words, objects,
signs or designs are used in any |
advertisement.
|
(b) "Drugs" means and includes (1) articles recognized
in |
the official United States Pharmacopoeia/National Formulary |
(USP/NF),
or any supplement thereto and being intended for and |
|
having for their
main use the diagnosis, cure, mitigation, |
treatment or prevention of
disease in man or other animals, as |
approved by the United States Food and
Drug Administration, |
but does not include devices or their components, parts,
or |
accessories; and (2) all other articles intended
for and |
having for their main use the diagnosis, cure, mitigation,
|
treatment or prevention of disease in man or other animals, as |
approved
by the United States Food and Drug Administration, |
but does not include
devices or their components, parts, or |
accessories; and (3) articles
(other than food) having for |
their main use and intended
to affect the structure or any |
function of the body of man or other
animals; and (4) articles |
having for their main use and intended
for use as a component |
or any articles specified in clause (1), (2)
or (3); but does |
not include devices or their components, parts or
accessories.
|
(c) "Medicines" means and includes all drugs intended for
|
human or veterinary use approved by the United States Food and |
Drug
Administration.
|
(d) "Practice of pharmacy" means: |
(1) the interpretation and the provision of assistance |
in the monitoring, evaluation, and implementation of |
prescription drug orders; |
(2) the dispensing of prescription drug orders; |
(3) participation in drug and device selection; |
(4) drug administration limited to the administration |
of oral, topical, injectable, and inhalation as follows: |
|
(A) in the context of patient education on the |
proper use or delivery of medications; |
(B) vaccination of patients 7 years of age and |
older pursuant to a valid prescription or standing |
order, by a physician licensed to practice medicine in |
all its branches, except for vaccinations covered by |
paragraph (15), upon completion of appropriate |
training, including how to address contraindications |
and adverse reactions set forth by rule, with |
notification to the patient's physician and |
appropriate record retention, or pursuant to hospital |
pharmacy and therapeutics committee policies and |
procedures. Eligible vaccines are those listed on the |
U.S. Centers for Disease Control and Prevention (CDC) |
Recommended Immunization Schedule, the CDC's Health |
Information for International Travel, or the U.S. Food |
and Drug Administration's Vaccines Licensed and |
Authorized for Use in the United States. As applicable |
to the State's Medicaid program and other payers, |
vaccines ordered and administered in accordance with |
this subsection shall be covered and reimbursed at no |
less than the rate that the vaccine is reimbursed when |
ordered and administered by a physician; |
(B-5) following the initial administration of |
long-acting or extended-release form opioid |
antagonists by a physician licensed to practice |
|
medicine in all its branches, administration of |
injections of long-acting or extended-release form |
opioid antagonists for the treatment of substance use |
disorder, pursuant to a valid prescription by a |
physician licensed to practice medicine in all its |
branches, upon completion of appropriate training, |
including how to address contraindications and adverse |
reactions, including, but not limited to, respiratory |
depression and the performance of cardiopulmonary |
resuscitation, set forth by rule, with notification to |
the patient's physician and appropriate record |
retention, or pursuant to hospital pharmacy and |
therapeutics committee policies and procedures; |
(C) administration of injections of |
alpha-hydroxyprogesterone caproate, pursuant to a |
valid prescription, by a physician licensed to |
practice medicine in all its branches, upon completion |
of appropriate training, including how to address |
contraindications and adverse reactions set forth by |
rule, with notification to the patient's physician and |
appropriate record retention, or pursuant to hospital |
pharmacy and therapeutics committee policies and |
procedures; and |
(D) administration of injections of long-term |
antipsychotic medications pursuant to a valid |
prescription by a physician licensed to practice |
|
medicine in all its branches, upon completion of |
appropriate training conducted by an Accreditation |
Council of Pharmaceutical Education accredited |
provider, including how to address contraindications |
and adverse reactions set forth by rule, with |
notification to the patient's physician and |
appropriate record retention, or pursuant to hospital |
pharmacy and therapeutics committee policies and |
procedures. |
(5) (blank); |
(6) drug regimen review; |
(7) drug or drug-related research; |
(8) the provision of patient counseling; |
(9) the practice of telepharmacy; |
(10) the provision of those acts or services necessary |
to provide pharmacist care; |
(11) medication therapy management; |
(12) the responsibility for compounding and labeling |
of drugs and devices (except labeling by a manufacturer, |
repackager, or distributor of non-prescription drugs and |
commercially packaged legend drugs and devices), proper |
and safe storage of drugs and devices, and maintenance of |
required records; |
(13) the assessment and consultation of patients and |
dispensing of hormonal contraceptives; and |
(14) the initiation, dispensing, or administration of
|
|
drugs, laboratory tests, assessments, referrals, and
|
consultations for human immunodeficiency virus |
pre-exposure prophylaxis and human immunodeficiency virus
|
post-exposure prophylaxis under Section 43.5 ; . |
(15) vaccination of patients 7 years of age and older |
for COVID-19 or influenza subcutaneously, intramuscularly, |
or orally as authorized, approved, or licensed by the |
United States Food and Drug Administration, pursuant to |
the following conditions: |
(A) the vaccine must be authorized or licensed by |
the United States Food and Drug Administration; |
(B) the vaccine must be ordered and administered |
according to the Advisory Committee on Immunization |
Practices standard immunization schedule; |
(C) the pharmacist must complete a course of |
training accredited by the Accreditation Council on |
Pharmacy Education or a similar health authority or |
professional body approved by the Division of |
Professional Regulation; |
(D) the pharmacist must have a current certificate |
in basic cardiopulmonary resuscitation; |
(E) the pharmacist must complete, during each |
State licensing period, a minimum of 2 hours of |
immunization-related continuing pharmacy education |
approved by the Accreditation Council on Pharmacy |
Education; |
|
(F) the pharmacist must comply with recordkeeping |
and reporting requirements of the jurisdiction in |
which the pharmacist administers vaccines, including |
informing the patient's primary-care provider, when |
available, and complying with requirements whereby the |
person administering a vaccine must review the vaccine |
registry or other vaccination records prior to |
administering the vaccine; and |
(G) the pharmacist must inform the pharmacist's |
patients who are less than 18 years old, as well as the |
adult caregiver accompanying the child, of the |
importance of a well-child visit with a pediatrician |
or other licensed primary-care provider and must refer |
patients as appropriate; |
(16) the ordering and administration of COVID-19 |
therapeutics subcutaneously, intramuscularly, or orally |
with notification to the patient's physician and |
appropriate record retention or pursuant to hospital |
pharmacy and therapeutics committee policies and |
procedures. Eligible therapeutics are those approved, |
authorized, or licensed by the United States Food and Drug |
Administration and must be administered subcutaneously, |
intramuscularly, or orally in accordance with that |
approval, authorization, or licensing; and |
(17) the ordering and administration of tests and |
screenings for (i) influenza, (ii) SARS-COV 2, and (iii) |
|
health conditions identified by a statewide public health |
emergency, as defined in the Illinois Emergency Management |
Agency Act, with notification to the patient's physician |
and appropriate record retention or pursuant to hospital |
pharmacy and therapeutics committee policies and |
procedures. Eligible tests and screenings are those |
approved, authorized, or licensed by the United States |
Food and Drug Administration and must be administered in |
accordance with that approval, authorization, or |
licensing. |
A pharmacist who orders or administers tests or |
screenings for health conditions described in this |
paragraph may use a test that may guide clinical |
decision-making for the health condition that is waived |
under the federal Clinical Laboratory Improvement |
Amendments of 1988 and regulations promulgated thereunder |
or any established screening procedure that is established |
under a statewide protocol. |
A pharmacist may delegate the administrative and |
technical tasks of performing a test for the health |
conditions described in this paragraph to a registered |
pharmacy technician or student pharmacist acting under the |
supervision of the pharmacist. |
A pharmacist who performs any of the acts defined as the |
practice of pharmacy in this State must be actively licensed |
as a pharmacist under this Act.
|
|
(e) "Prescription" means and includes any written, oral, |
facsimile, or
electronically transmitted order for drugs
or |
medical devices, issued by a physician licensed to practice |
medicine in
all its branches, dentist, veterinarian, podiatric |
physician, or
optometrist, within the
limits of his or her |
license, by a physician assistant in accordance with
|
subsection (f) of Section 4, or by an advanced practice |
registered nurse in
accordance with subsection (g) of Section |
4, containing the
following: (1) name
of the patient; (2) date |
when prescription was issued; (3) name
and strength of drug or |
description of the medical device prescribed;
and (4) |
quantity; (5) directions for use; (6) prescriber's name,
|
address,
and signature; and (7) DEA registration number where |
required, for controlled
substances.
The prescription may, but |
is not required to, list the illness, disease, or condition |
for which the drug or device is being prescribed. DEA |
registration numbers shall not be required on inpatient drug |
orders. A prescription for medication other than controlled |
substances shall be valid for up to 15 months from the date |
issued for the purpose of refills, unless the prescription |
states otherwise.
|
(f) "Person" means and includes a natural person, |
partnership,
association, corporation, government entity, or |
any other legal
entity.
|
(g) "Department" means the Department of Financial and
|
Professional Regulation.
|
|
(h) "Board of Pharmacy" or "Board" means the State Board
|
of Pharmacy of the Department of Financial and Professional |
Regulation.
|
(i) "Secretary"
means the Secretary
of Financial and |
Professional Regulation.
|
(j) "Drug product selection" means the interchange for a
|
prescribed pharmaceutical product in accordance with Section |
25 of
this Act and Section 3.14 of the Illinois Food, Drug and |
Cosmetic Act.
|
(k) "Inpatient drug order" means an order issued by an |
authorized
prescriber for a resident or patient of a facility |
licensed under the
Nursing Home Care Act, the ID/DD Community |
Care Act, the MC/DD Act, the Specialized Mental Health |
Rehabilitation Act of 2013, the Hospital Licensing Act, or the |
University of Illinois Hospital Act, or a facility which is |
operated by the Department of Human
Services (as successor to |
the Department of Mental Health
and Developmental |
Disabilities) or the Department of Corrections.
|
(k-5) "Pharmacist" means an individual health care |
professional and
provider currently licensed by this State to |
engage in the practice of
pharmacy.
|
(l) "Pharmacist in charge" means the licensed pharmacist |
whose name appears
on a pharmacy license and who is |
responsible for all aspects of the
operation related to the |
practice of pharmacy.
|
(m) "Dispense" or "dispensing" means the interpretation, |
|
evaluation, and implementation of a prescription drug order, |
including the preparation and delivery of a drug or device to a |
patient or patient's agent in a suitable container |
appropriately labeled for subsequent administration to or use |
by a patient in accordance with applicable State and federal |
laws and regulations.
"Dispense" or "dispensing" does not mean |
the physical delivery to a patient or a
patient's |
representative in a home or institution by a designee of a |
pharmacist
or by common carrier. "Dispense" or "dispensing" |
also does not mean the physical delivery
of a drug or medical |
device to a patient or patient's representative by a
|
pharmacist's designee within a pharmacy or drugstore while the |
pharmacist is
on duty and the pharmacy is open.
|
(n) "Nonresident pharmacy"
means a pharmacy that is |
located in a state, commonwealth, or territory
of the United |
States, other than Illinois, that delivers, dispenses, or
|
distributes, through the United States Postal Service, |
commercially acceptable parcel delivery service, or other |
common
carrier, to Illinois residents, any substance which |
requires a prescription.
|
(o) "Compounding" means the preparation and mixing of |
components, excluding flavorings, (1) as the result of a |
prescriber's prescription drug order or initiative based on |
the prescriber-patient-pharmacist relationship in the course |
of professional practice or (2) for the purpose of, or |
incident to, research, teaching, or chemical analysis and not |
|
for sale or dispensing. "Compounding" includes the preparation |
of drugs or devices in anticipation of receiving prescription |
drug orders based on routine, regularly observed dispensing |
patterns. Commercially available products may be compounded |
for dispensing to individual patients only if all of the |
following conditions are met: (i) the commercial product is |
not reasonably available from normal distribution channels in |
a timely manner to meet the patient's needs and (ii) the |
prescribing practitioner has requested that the drug be |
compounded.
|
(p) (Blank).
|
(q) (Blank).
|
(r) "Patient counseling" means the communication between a |
pharmacist or a student pharmacist under the supervision of a |
pharmacist and a patient or the patient's representative about |
the patient's medication or device for the purpose of |
optimizing proper use of prescription medications or devices. |
"Patient counseling" may include without limitation (1) |
obtaining a medication history; (2) acquiring a patient's |
allergies and health conditions; (3) facilitation of the |
patient's understanding of the intended use of the medication; |
(4) proper directions for use; (5) significant potential |
adverse events; (6) potential food-drug interactions; and (7) |
the need to be compliant with the medication therapy. A |
pharmacy technician may only participate in the following |
aspects of patient counseling under the supervision of a |
|
pharmacist: (1) obtaining medication history; (2) providing |
the offer for counseling by a pharmacist or student |
pharmacist; and (3) acquiring a patient's allergies and health |
conditions.
|
(s) "Patient profiles" or "patient drug therapy record" |
means the
obtaining, recording, and maintenance of patient |
prescription
information, including prescriptions for |
controlled substances, and
personal information.
|
(t) (Blank).
|
(u) "Medical device" or "device" means an instrument, |
apparatus, implement, machine,
contrivance, implant, in vitro |
reagent, or other similar or related article,
including any |
component part or accessory, required under federal law to
|
bear the label "Caution: Federal law requires dispensing by or |
on the order
of a physician". A seller of goods and services |
who, only for the purpose of
retail sales, compounds, sells, |
rents, or leases medical devices shall not,
by reasons |
thereof, be required to be a licensed pharmacy.
|
(v) "Unique identifier" means an electronic signature, |
handwritten
signature or initials, thumb print, or other |
acceptable biometric
or electronic identification process as |
approved by the Department.
|
(w) "Current usual and customary retail price" means the |
price that a pharmacy charges to a non-third-party payor.
|
(x) "Automated pharmacy system" means a mechanical system |
located within the confines of the pharmacy or remote location |
|
that performs operations or activities, other than compounding |
or administration, relative to storage, packaging, dispensing, |
or distribution of medication, and which collects, controls, |
and maintains all transaction information. |
(y) "Drug regimen review" means and includes the |
evaluation of prescription drug orders and patient records for |
(1)
known allergies; (2) drug or potential therapy |
contraindications;
(3) reasonable dose, duration of use, and |
route of administration, taking into consideration factors |
such as age, gender, and contraindications; (4) reasonable |
directions for use; (5) potential or actual adverse drug |
reactions; (6) drug-drug interactions; (7) drug-food |
interactions; (8) drug-disease contraindications; (9) |
therapeutic duplication; (10) patient laboratory values when |
authorized and available; (11) proper utilization (including |
over or under utilization) and optimum therapeutic outcomes; |
and (12) abuse and misuse.
|
(z) "Electronically transmitted prescription" means a |
prescription that is created, recorded, or stored by |
electronic means; issued and validated with an electronic |
signature; and transmitted by electronic means directly from |
the prescriber to a pharmacy. An electronic prescription is |
not an image of a physical prescription that is transferred by |
electronic means from computer to computer, facsimile to |
facsimile, or facsimile to computer.
|
(aa) "Medication therapy management services" means a |
|
distinct service or group of services offered by licensed |
pharmacists, physicians licensed to practice medicine in all |
its branches, advanced practice registered nurses authorized |
in a written agreement with a physician licensed to practice |
medicine in all its branches, or physician assistants |
authorized in guidelines by a supervising physician that |
optimize therapeutic outcomes for individual patients through |
improved medication use. In a retail or other non-hospital |
pharmacy, medication therapy management services shall consist |
of the evaluation of prescription drug orders and patient |
medication records to resolve conflicts with the following: |
(1) known allergies; |
(2) drug or potential therapy contraindications; |
(3) reasonable dose, duration of use, and route of |
administration, taking into consideration factors such as |
age, gender, and contraindications; |
(4) reasonable directions for use; |
(5) potential or actual adverse drug reactions; |
(6) drug-drug interactions; |
(7) drug-food interactions; |
(8) drug-disease contraindications; |
(9) identification of therapeutic duplication; |
(10) patient laboratory values when authorized and |
available; |
(11) proper utilization (including over or under |
utilization) and optimum therapeutic outcomes; and |
|
(12) drug abuse and misuse. |
"Medication therapy management services" includes the |
following: |
(1) documenting the services delivered and |
communicating the information provided to patients' |
prescribers within an appropriate time frame, not to |
exceed 48 hours; |
(2) providing patient counseling designed to enhance a |
patient's understanding and the appropriate use of his or |
her medications; and |
(3) providing information, support services, and |
resources designed to enhance a patient's adherence with |
his or her prescribed therapeutic regimens. |
"Medication therapy management services" may also include |
patient care functions authorized by a physician licensed to |
practice medicine in all its branches for his or her |
identified patient or groups of patients under specified |
conditions or limitations in a standing order from the |
physician. |
"Medication therapy management services" in a licensed |
hospital may also include the following: |
(1) reviewing assessments of the patient's health |
status; and |
(2) following protocols of a hospital pharmacy and |
therapeutics committee with respect to the fulfillment of |
medication orders.
|
|
(bb) "Pharmacist care" means the provision by a pharmacist |
of medication therapy management services, with or without the |
dispensing of drugs or devices, intended to achieve outcomes |
that improve patient health, quality of life, and comfort and |
enhance patient safety.
|
(cc) "Protected health information" means individually |
identifiable health information that, except as otherwise |
provided, is:
|
(1) transmitted by electronic media; |
(2) maintained in any medium set forth in the |
definition of "electronic media" in the federal Health |
Insurance Portability and Accountability Act; or |
(3) transmitted or maintained in any other form or |
medium. |
"Protected health information" does not include |
individually identifiable health information found in: |
(1) education records covered by the federal Family |
Educational Right and Privacy Act; or |
(2) employment records held by a licensee in its role |
as an employer. |
(dd) "Standing order" means a specific order for a patient |
or group of patients issued by a physician licensed to |
practice medicine in all its branches in Illinois. |
(ee) "Address of record" means the designated address |
recorded by the Department in the applicant's application file |
or licensee's license file maintained by the Department's |
|
licensure maintenance unit. |
(ff) "Home pharmacy" means the location of a pharmacy's |
primary operations.
|
(gg) "Email address of record" means the designated email |
address recorded by the Department in the applicant's |
application file or the licensee's license file, as maintained |
by the Department's licensure maintenance unit. |
(Source: P.A. 101-349, eff. 1-1-20; 102-16, eff. 6-17-21; |
102-103, eff. 1-1-22; 102-558, eff. 8-20-21; 102-813, eff. |
5-13-22; 102-1051, eff. 1-1-23 .) |
(225 ILCS 85/9.6 new) |
Sec. 9.6. Administration of vaccines and therapeutics by |
registered pharmacy technicians and student pharmacists. |
(a) Under the supervision of an appropriately trained |
pharmacist, a registered pharmacy technician or student |
pharmacist may administer COVID-19 and influenza vaccines |
subcutaneously, intramuscularly, or orally as authorized, |
approved, or licensed by the United States Food and Drug |
Administration, subject to the following conditions: |
(1) the vaccination must be ordered by the supervising |
pharmacist; |
(2) the supervising pharmacist must be readily and |
immediately available to the immunizing pharmacy |
technician or student pharmacist; |
(3) the pharmacy technician or student pharmacist must |
|
complete a practical training program that is approved by |
the Accreditation Council for Pharmacy Education and that |
includes hands-on injection technique training and |
training in the recognition and treatment of emergency |
reactions to vaccines; |
(4) the pharmacy technician or student pharmacist must |
have a current certificate in basic cardiopulmonary |
resuscitation; |
(5) the pharmacy technician or student pharmacist must |
complete, during the relevant licensing period, a minimum |
of 2 hours of immunization-related continuing pharmacy |
education that is approved by the Accreditation Council |
for Pharmacy Education; |
(6) the supervising pharmacist must comply with all |
relevant recordkeeping and reporting requirements; |
(7) the supervising pharmacist must be responsible for |
complying with requirements related to reporting adverse |
events; |
(8) the supervising pharmacist must review the vaccine |
registry or other vaccination records prior to ordering |
the vaccination to be administered by the pharmacy |
technician or student pharmacist; |
(9) the pharmacy technician or student pharmacist |
must, if the patient is 18 years of age or younger, inform |
the patient and the adult caregiver accompanying the |
patient of the importance of a well-child visit with a |
|
pediatrician or other licensed primary-care provider and |
must refer patients as appropriate; |
(10) in the case of a COVID-19 vaccine, the |
vaccination must be ordered and administered according to |
the Advisory Committee on Immunization Practices' COVID-19 |
vaccine recommendations; |
(11) in the case of a COVID-19 vaccine, the |
supervising pharmacist must comply with any applicable |
requirements or conditions of use as set forth in the |
Centers for Disease Control and Prevention COVID-19 |
vaccination provider agreement and any other federal |
requirements that apply to the administration of COVID-19 |
vaccines being administered; and |
(12) the registered pharmacy technician or student |
pharmacist and the supervising pharmacist must comply with |
all other requirements of this Act and the rules adopted |
thereunder pertaining to the administration of drugs. |
(b) Under the supervision of an appropriately trained |
pharmacist, a registered pharmacy technician or student |
pharmacist may administer COVID-19 therapeutics |
subcutaneously, intramuscularly, or orally as authorized, |
approved, or licensed by the United States Food and Drug |
Administration, subject to the following conditions: |
(1) the COVID-19 therapeutic must be authorized, |
approved or licensed by the United States Food and Drug |
Administration; |
|
(2) the COVID-19 therapeutic must be administered |
subcutaneously, intramuscularly, or orally in accordance |
with the United States Food and Drug Administration |
approval, authorization, or licensing; |
(3) a pharmacy technician or student pharmacist |
practicing pursuant to this Section must complete a |
practical training program that is approved by the |
Accreditation Council for Pharmacy Education and that |
includes hands-on injection technique training, clinical |
evaluation of indications and contraindications of |
COVID-19 therapeutics training, training in the |
recognition and treatment of emergency reactions to |
COVID-19 therapeutics, and any additional training |
required in the United States Food and Drug Administration |
approval, authorization, or licensing; |
(4) the pharmacy technician or student pharmacist must |
have a current certificate in basic cardiopulmonary |
resuscitation; |
(5) the pharmacy technician or student pharmacist must |
comply with any applicable requirements or conditions of |
use that apply to the administration of COVID-19 |
therapeutics; |
(6) the supervising pharmacist must comply with all |
relevant recordkeeping and reporting requirements; |
(7) the supervising pharmacist must be readily and |
immediately available to the pharmacy technician or |
|
student pharmacist; and |
(8) the registered pharmacy technician or student |
pharmacist and the supervising pharmacist must comply with |
all other requirements of this Act and the rules adopted |
thereunder pertaining to the administration of drugs. |
Section 55. The Illinois Speech-Language Pathology and
|
Audiology Practice Act is amended by changing Section 8.8 as |
follows:
|
(225 ILCS 110/8.8)
|
(Section scheduled to be repealed on January 1, 2028)
|
Sec. 8.8. Supervision of speech-language pathology |
assistants.
|
(a) A speech-language pathology assistant shall practice |
only under the
supervision of a speech-language pathologist |
who has at least 2 years
experience in addition to the |
supervised professional experience required under
subsection |
(f) of Section 8 of this Act. A speech-language pathologist |
who
supervises a speech-language pathology assistant (i) must |
have completed at least 6
clock hours of training in |
supervision related to speech-language pathology, and (ii) |
must complete at least 2 clock hours of continuing education |
in supervision related to speech-language pathology in each |
new licensing cycle after completion of the initial training |
required under item (i). The Department shall promulgate rules |
|
describing the supervision
training requirements. The rules |
may allow a speech-language pathologist to
apply to the Board |
for an exemption from this training requirement based upon
|
prior supervisory experience.
|
(b) A speech-language pathology assistant must be under |
the direct
supervision of a speech-language pathologist at |
least 30% of the
speech-language pathology assistant's actual |
patient or client contact time per
patient or client during |
the first 90 days of initial employment as a
speech-language |
pathology assistant. Thereafter, a speech-language pathology
|
assistant must be under the direct supervision of a |
speech-language
pathologist at least 20% of the |
speech-language pathology assistant's actual
patient or client |
contact time per patient or client. Supervision of a
|
speech-language pathology assistant beyond the minimum |
requirements of this
subsection may be imposed at the |
discretion of the supervising
speech-language pathologist. A |
supervising speech-language pathologist must
be available to |
communicate with a speech-language pathology assistant
|
whenever the assistant is in contact with a patient or client.
|
(c) A speech-language pathologist that supervises a |
speech-language
pathology assistant must document direct |
supervision activities. At a
minimum, supervision |
documentation must provide (i) information regarding the
|
quality of the speech-language pathology assistant's |
performance of
assigned duties, and (ii) verification that |
|
clinical activity is limited to
duties specified in Section |
8.7.
|
(d) A full-time speech-language pathologist may supervise |
no more than 2
speech-language pathology assistants. A |
speech-language pathologist
that does not work full-time may |
supervise no more than one speech-language
pathology |
assistant.
|
(e) For purposes of this Section, "direct supervision" |
means on-site,
in-view
observation and guidance by a |
speech-language pathologist while an
assigned activity is |
performed by the speech-language pathology assistant or |
supervision by a speech-language pathologist by way of video |
conferencing technology during telehealth practice .
|
(Source: P.A. 100-530, eff. 1-1-18 .)
|
Section 65. The Radiation Protection Act of 1990 is |
amended by changing Section 7a as follows: |
(420 ILCS 40/7a) (from Ch. 111 1/2, par. 210-7a)
|
(Section scheduled to be repealed on January 1, 2027)
|
Sec. 7a. Certification of industrial radiographers.
|
(a) Beginning January 1, 1993, no person may perform |
industrial
radiography unless he or she is certified by the |
Department of Nuclear Safety
or its successor, the Illinois |
Emergency Management Agency, to perform
industrial |
radiography. The Agency shall promulgate
regulations
|
|
establishing standards and procedures for certification of |
industrial
radiographers. The regulations may include, without |
limitation, provisions
specifying a minimum course of study |
and requiring that individuals seeking
certification pass an |
examination administered or approved by the
Agency. Industrial |
radiography certification shall be valid
for 5
years, except |
that certifications for industrial radiography trainees
shall |
be valid for 2 years or shall be extended pursuant to |
subsection (e) . The Agency shall establish by
regulation
|
standards and procedures for renewal of certification. The |
regulations shall
provide that certification for industrial |
radiography trainees shall be
nonrenewable.
|
(b) The regulations of the Department of Nuclear Safety,
|
as the predecessor agency of the Illinois Emergency Management |
Agency,
shall provide for provisional
certification of persons |
who performed industrial radiography before
January 1, 1993. |
In order to obtain provisional certification, the industrial
|
radiographer must apply to the Department no later than |
January 1, 1993.
Provisional certification shall be valid for |
2 years, except for those certifications extended pursuant to |
subsection (e), provided that a
person who has obtained a |
provisional certification must take an
examination that is |
administered or approved by the Department within 12
months of |
the date on which the provisional certification was issued. |
Upon
passing the examination, the Department shall certify the |
individual as an
industrial radiographer. Provisional |
|
certification shall be nonrenewable.
|
(c) The Agency may, by regulation, assess certification
|
fees and
fees to recover the cost of examining applicants for |
certification.
|
(d) The Agency may suspend or revoke the certification of
|
an
industrial radiographer, or take other action as provided |
in Sections 36
and 38 of this Act, if a certified industrial |
radiographer violates this
Act or any rule or regulation |
promulgated under this Act, or otherwise
endangers the safety |
of himself, his co-workers, or members of the general
public. |
It shall be a violation of this Act for any person to allow an
|
individual who is not a certified industrial radiographer to |
perform
industrial radiography.
|
(e) The Agency may extend the term of existing |
certifications for industrial radiographers and industrial |
radiographer trainees in 90-day increments, not to exceed a |
maximum period of 6 months beyond the initial term, to allow |
individuals time to meet the examination criteria. Industrial |
radiographers and industrial radiographer trainees shall meet |
all other requirements as set forth by the Agency. |
(Source: P.A. 94-104, eff. 7-1-05 .)
|
Section 99. Effective date. This Act takes effect upon |
becoming law.
|